Cargando…
PI3K inhibitors in inflammation, autoimmunity and cancer
The healthy immune system protects against infection and malignant transformation without causing significant damage to host tissues. Immune dysregulation results in diverse pathologies including autoimmune disease, chronic inflammatory disorders, allergies as well as immune deficiencies and cancer....
Autores principales: | Stark, Anne-Katrien, Sriskantharajah, Srividya, Hessel, Edith M, Okkenhaug, Klaus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518027/ https://www.ncbi.nlm.nih.gov/pubmed/26093105 http://dx.doi.org/10.1016/j.coph.2015.05.017 |
Ejemplares similares
-
PI3Kδ hyper-activation promotes development of B cells that exacerbate Streptococcus pneumoniae infection in an antibody-independent manner
por: Stark, Anne-Katrien, et al.
Publicado: (2018) -
The Therapeutic Potential for PI3K Inhibitors in Autoimmune Rheumatic Diseases
por: Banham-Hall, Edward, et al.
Publicado: (2012) -
PI3K Signaling in B Cell and T Cell Biology
por: Okkenhaug, Klaus, et al.
Publicado: (2014) -
PI3K Signaling in Normal B Cells and Chronic Lymphocytic
Leukemia (CLL)
por: Okkenhaug, Klaus, et al.
Publicado: (2015) -
PI3K in T Cell Adhesion and Trafficking
por: Johansen, Kristoffer H., et al.
Publicado: (2021)